These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22926289)

  • 1. Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study.
    Lu JL; Tang QL; De Liu F; Hui JH
    Urol Res; 2012 Dec; 40(6):757-62. PubMed ID: 22926289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamsulosin and tolterodine in the medical expulsive therapy for intramural ureteral stones with vesical irritability: a prospective randomized study.
    Lv JL; Tang Ql
    Urolithiasis; 2013 Oct; 41(5):417-21. PubMed ID: 23963102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tolterodine for medical treatment of intramural ureteral stone with vesical irritability.
    Lv JL; Tang QN; Hui JH; Lu FD
    Urol Res; 2011 Jun; 39(3):213-6. PubMed ID: 21069309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of efficacy of use of tamsulosin and/or tolterodine for medical treatment of distal ureteral stones.
    Erturhan S; Erbagci A; Yagci F; Celik M; Solakhan M; Sarica K
    Urology; 2007 Apr; 69(4):633-6. PubMed ID: 17445639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of selective alpha1D-blocker naftopidil as medical expulsive therapy for distal ureteral stones.
    Sun X; He L; Ge W; Lv J
    J Urol; 2009 Apr; 181(4):1716-20. PubMed ID: 19233432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones.
    Lv JL; Tang QL
    Urolithiasis; 2014 Dec; 42(6):541-7. PubMed ID: 25139150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
    Kaplan SA; Roehrborn CG; Rovner ES; Carlsson M; Bavendam T; Guan Z
    JAMA; 2006 Nov; 296(19):2319-28. PubMed ID: 17105794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial.
    Kohjimoto Y; Hagino K; Ogawa T; Inagaki T; Kitamura S; Nishihata M; Iba A; Matsumura N; Hara I
    World J Urol; 2015 Dec; 33(12):2125-9. PubMed ID: 25869815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Chapple C; Herschorn S; Abrams P; Sun F; Brodsky M; Guan Z
    Eur Urol; 2009 Sep; 56(3):534-41. PubMed ID: 19070418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Naftopidil in the Medical Expulsion Therapy for Distal Ureteral Stone: A Systematic Review and Meta-Analysis.
    Li J; Tang Z; Gao L; Li J; Qin F; Yuan J
    J Endourol; 2017 May; 31(5):427-437. PubMed ID: 28306333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
    Gacci M; Novara G; De Nunzio C; Tubaro A; Schiavina R; Brunocilla E; Sebastianelli A; Salvi M; Oelke M; Gravas S; Carini M; Serni S
    BMC Urol; 2014 Oct; 14():84. PubMed ID: 25348235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    Tsuzaka Y; Matsushima H; Kaneko T; Yamaguchi T; Homma Y
    Int J Urol; 2011 Nov; 18(11):792-5. PubMed ID: 21917021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones.
    Zhou SG; Lu JL; Hui JH
    World J Urol; 2011 Dec; 29(6):767-71. PubMed ID: 21845472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of expulsion of ureteral stones by addition of α1-blockers to conservative therapy.
    Ohgaki K; Horiuchi K; Hikima N; Kondo Y
    Scand J Urol Nephrol; 2010 Dec; 44(6):420-4. PubMed ID: 20604720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of tolterodine extended release and alfuzosin for the treatment of double-j stent-related symptoms.
    Park SC; Jung SW; Lee JW; Rim JS
    J Endourol; 2009 Nov; 23(11):1913-7. PubMed ID: 19814699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
    Söylemez H; Bodakci MN; Hatipoglu NK
    Int J Urol; 2012 Aug; 19(8):792; author reply 792-3. PubMed ID: 22435593
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Speakman MJ
    Eur Urol; 2009 Sep; 56(3):542-3. PubMed ID: 19070420
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers.
    Dmochowski R
    Eur Urol; 2009 Sep; 56(3):542. PubMed ID: 19070419
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.